Comparison of MRI, EEG, EPs and ECD‐SPECT in Wilson's disease
暂无分享,去创建一个
M. Giagheddu | G. Tamburini | M. Piga | P. Tacconi | A. Giagheddu | A. Serra | P. Siotto | L. Satta | L. Demelia | F. Marrosu | Alessandra Serra | Francesco Marrosu | Marcello Giagheddu | Matteo Piga | Paolo Tacconi | Paolo Siotto
[1] THE PATHOLOGY OF THE NERVOUS SYSTEM IN A CASE OF PROGRESSIVE LENTICULAR DEGENERATION , 1917 .
[2] W. Spielmeyer. Die histopathologische Zusammengehörigkeit der Wilsonschen Krankheit und der Pseudosklerose , 1920 .
[3] A. Braunmühl. Die Rinden-Markkomponente im anatomischen Bild der Wilson-Pseudosklerosegruppe , 1930 .
[4] A. Wallgren,et al. SOME ASPECTS OF HEPATOLENTICULAR DEGENERATION AND ITS PATHOGENESIS , 1934 .
[5] I. Freiman,et al. HEPATO-LENTICULAR DEGENERATION (WILSON'S DISEASE) FOLLOWING SPLENECTOMY; INTER-RELATIONSHIP OF THE RETICULO-ENDOTHELIAL AND CENTRAL NERVOUS SYSTEMS , 1941 .
[6] N. W. Konowalow. Histopathologie der hepatolentikulären Degeneration: II. Mitteilung. Histopathologie der Rindenerweichungen , 1941 .
[7] I. Freiman,et al. Progressive lenticular degeneration , 1942 .
[8] R. Richter. The pallial component in hepato-lenticular degeneration. , 1948, Journal of neuropathology and experimental neurology.
[9] THE PALLIAL COMPONENT IN HEPATOLENTICULAR DEGENERATION , 1948 .
[10] Unusual mental symptoms in a case of hepatolenticular degeneration. , 1950, Diseases of the nervous system.
[11] Effect of dimercaprol (BAL) in hepatolenticular degeneration; report of a case, with clinical and electroencephalographic study. , 1953, A.M.A. archives of neurology and psychiatry.
[12] J. Walshe. Wilson's disease; new oral therapy. , 1956, The Lancet.
[13] P. Loiseau,et al. [Electroencephalogram in Wilson-Westphal-Strumpell disease]. , 1957, L'Encephale.
[15] F. Kolb,et al. Hepatolenticular degeneration. Clinical, biochemical and pathologic study of a patient with fulminant course aggravated by treatment with BAL and versenate. , 1960, The American journal of medicine.
[16] The electroencephalogram in hepatolenticular degeneration (Wilson's disease). , 1962, Electroencephalography and clinical neurophysiology.
[17] K. A. Kooi,et al. The electroencephalogram in hepato-lenticular degeneration (Wilson's disease) , 1962 .
[18] A GENETIC, BIOCHEMICAL AND CLINICAL STUDY OF WILSON'S DISEASE AMONG CHINESE IN TAIWAN. , 1963, Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui.
[19] S. Schulman,et al. WILSON'S DISEASE: A CASE WITH ALMOST TOTAL LOSS OF CEREBRAL WHITE MATTER*,†,‡ , 1963 .
[20] CLINICAL AND PATHOLOGICAL ASPECTS OF WILSON'S DISEASE IN CASES OF ONE AND THE SAME FAMILY. , 1965, The Tohoku journal of experimental medicine.
[21] [Hepatocerebral degeneration (Wilson's disease). I. Pathogenesis, clinical aspects, electroencephalogram]. , 1965, Medizinische Klinik.
[22] Richard H. Mattson,et al. Seizures in Wilson's disease , 1967, Neurology.
[23] Hereditary hepatolenticular degeneration (Wilson's disease). Report of the first case in Jamaica. , 1968, Tropical and geographical medicine.
[24] EEG changes in Wilson's disease. , 1969, Electroencephalography and clinical neurophysiology.
[25] An electroencephalographic and psychiatric study of 32 insane murderers. , 1969 .
[26] Uncommon EEG findings in hepato-lenticular degeneration. , 1969, Electroencephalography and clinical neurophysiology.
[27] S. Otsuki,et al. A case of Wilson's disease with enormous cavity formation of cerebral white matter , 1972, Neurology.
[28] Manifestations convulsives dans la maladie de Wilson , 1973 .
[29] J. Walshe. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. , 1973, The Quarterly journal of medicine.
[30] B. Westmoreland,et al. Wilson's disease. Electroencephalographic and evoked potential studies. , 1974, Mayo Clinic proceedings.
[31] A. Anzil,et al. Ultrastructure of brain and nerve biopsy tissue in Wilson disease. , 1974, Archives of neurology.
[32] T. Miyakawa,et al. An autopsy case of the "demyelinating type" of Wilson's disease. , 1976, Acta neuropathologica.
[33] T. Hoogenraad,et al. Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration). , 1979, European neurology.
[34] N. Chu,et al. Sensory evoked potentials in Wilson's disease. , 1986, Brain : a journal of neurology.
[35] S. Nevsimalova,et al. An EEG study of Wilson's disease. Findings in patients and heterozygous relatives. , 1986, Electroencephalography and clinical neurophysiology.
[36] A. Young,et al. Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging. , 1987, Archives of neurology.
[37] P. Sharp,et al. Technetium-99m HMPAO imaging in patients with basal ganglia disease. , 1988, The British journal of radiology.
[38] T. Dening,et al. Wilson's disease and epilepsy. , 1988, Brain : a journal of neurology.
[39] [Wilson's disease: demonstration of lesions of the cortex and white matter by MRI]. , 1988, Revue neurologique.
[40] N. Chu. Clinical, CT and evoked potential manifestations inWilson's disease with cerebral white matter involvement , 1989, Clinical Neurology and Neurosurgery.
[41] P. Satishchandra,et al. Visual and brain stem auditory evoked responses in Wilson's disease , 1989, Acta neurologica Scandinavica.
[42] N. Chu. Motor evoked potentials in Wilson's disease: early and late motor responses , 1990, Journal of the Neurological Sciences.
[43] R. Shakir,et al. Brainstem auditory evoked potentials in Wilson's disease , 1990, Journal of the Neurological Sciences.
[44] L. Prayer,et al. Evoked potentials in assessment and follow-up of patients with Wilson's disease , 1990, The Lancet.
[45] [Wilson's disease: computed tomography and magnetic resonance imaging]. , 1990, Neurologia.
[46] N. Chu,et al. EEG spectral analysis and topographic mapping in Wilson's disease , 1991, Journal of the Neurological Sciences.
[47] C. Kirsch,et al. SPECT imaging of dopamine D2 receptors with 123I‐IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease , 1991, Nuclear medicine communications.
[48] K. Yoshikawa,et al. Mid-brain pathology of Wilson's disease: MRI analysis of three cases. , 1991, Journal of Neurology Neurosurgery & Psychiatry.
[49] A. Young,et al. Initial therapy of patients with Wilson's disease with tetrathiomolybdate. , 1991, Archives of neurology.
[50] H. Imhof,et al. Comparison of functional and structural brain disturbances in Wilson's disease , 1991, Neurology.
[51] C. Madl,et al. Detailed evaluation of evoked potentials in Wilson's disease. , 1992, Electroencephalography and clinical neurophysiology.
[52] T. Vogl,et al. Decrease of D2 receptors indicated by 123I‐iodobenzamide single‐photon emission computed tomography relates to neurological deficit in treated Wilson's disease , 1992, Annals of neurology.
[53] A. Beydoun,et al. Correlation of evoked potential and MRI findings in Wilson's disease , 1993, Neurology.
[54] E. Barbosa,et al. Wilson's disease: magnetic resonance imaging (MRI) with clinical correlations in 16 cases. , 1993, Revista paulista de medicina.
[55] H. Hefter,et al. The diagnostic value of multi-modality evoked potentials in Wilson's disease. , 1994, Electromyography and clinical neurophysiology.
[56] T. Vogl,et al. Treatment with D‐penicillamine improves dopamine D2‐receptor binding and T2‐signal intensity in de novo Wilson's disease , 1994, Neurology.
[57] H. Hefter,et al. Motor impairment in Wilson's disease 3: the clinical impact of pyramidal tract involvement , 1994, Acta neurologica Scandinavica.
[58] K. Kendler,et al. An analysis of the clinical features of familial schizophrenia , 1994, Acta psychiatrica Scandinavica.
[59] J. Heckmann,et al. Wilson's disease: neurological and magnetic resonance imaging improvement on zinc treatment. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[60] J. Roh,et al. Initial and follow‐up brain MRI findings and correlation with the clinical course in Wilson's disease , 1994, Neurology.
[61] Recurrent pulmonary embolism and chronic multivessel thrombophlebitis associated with a right-to-left shunt in the antiphospholipid syndrome. , 1995, Clinical nuclear medicine.
[62] G. Jansen,et al. Cranial MR in Wilson disease: abnormal white matter in extrapyramidal and pyramidal tracts. , 1995, AJNR. American journal of neuroradiology.
[63] H. Fukuyama,et al. Initial clinical experiences with dopamine D2 receptor imaging by means of 2′-iodospiperone and single-photon emission computed tomography , 1995, Annals of nuclear medicine.
[64] O. Pogarell,et al. Epidemiological, genetic, pharmacological, kinesiological, nuclear medical (IBZM-SPECT), standard and functional MRI studies on Parkinson's disease and related disorders and economic evaluation of Parkinson's disease therapy--clinical projects in the BMFT-research program Munich: "Parkinson's diseas , 1995, Journal of neural transmission. Supplementum.
[65] Brain SPECT in Wilson's disease. , 1995, Clinical nuclear medicine.
[66] Motor cortex threshold in Wilson's disease (transcranial magnetic stimulation). , 1996, Neurologia i neurochirurgia polska.
[67] Y. Shinohara,et al. Reversible Magnetic Resonance Imaging Lesions in Wilson's Disease: Clinical‐Anatomical Correlation , 1996, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[68] I. Wilkinson,et al. Cranial MR imaging in Wilson's disease. , 1996, AJR. American journal of roentgenology.
[69] B S Polla,et al. Cellular basis of ECD brain retention. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[70] N. Chu,et al. Wilson's disease: resolution of MRI lesions following long‐term oral zinc therapy , 1996, Acta neurologica Scandinavica.
[71] W. Takahashi,et al. A Wilson's disease patient with prominent cerebral white matter lesions: five-year follow-up by MRI. , 1996, European neurology.
[72] D. Slosman,et al. Cellular Basis of BCD Brain Retention , 1996 .
[73] D. Lee,et al. Dopamine transporter imaging with [123I]-β-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson’s disease , 1998, Journal of neurology, neurosurgery, and psychiatry.
[74] Y. Kuo,et al. MRI Manifestations of Wilson's Disease and its Change in Response to Treatment , 1998 .